Anebulo Pharmaceuticals ANEB
OTC ANEB
$0.29 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Anebulo Pharmaceuticals (ANEB) Amortization of Deferred Charges (2024 - 2025)

Updated

Analysis

Anebulo Pharmaceuticals (ANEB) Amortization of Deferred Charges (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,130.49 Bn 1,099.07 Bn 19.71 Bn
2 Johnson & Johnson 635.65 Bn 555.51 Bn 17.30 Bn
3 AbbVie 505.44 Bn 478.55 Bn 12.70 Bn
4 Merck 358.27 Bn 312.65 Bn 12.21 Bn
5 Novartis Ag 291.57 Bn 255.56 Bn 11.24 Bn
6 Astrazeneca 265.15 Bn 238.84 Bn 12.86 Bn
7 Amgen 237.41 Bn 192.81 Bn 7.24 Bn
8 Gilead Sciences 195.01 Bn 169.21 Bn 6.22 Bn
9 Pfizer 171.23 Bn 117.87 Bn 10.94 Bn
10 Anebulo Pharmaceuticals 11.91 Mn -32.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 17,439.00
Sep 30, 2025 17,440.00
Jun 30, 2025 17,439.00
Mar 31, 2025 245,182.00
Dec 31, 2024 59,696.00
Sep 30, 2024 59,697.00
Jun 30, 2024 59,696.00
Mar 31, 2024 59,696.00
API Access

Anebulo Pharmaceuticals Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=ANEB&period=max&api_key=YOUR_API_KEY